⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

FTSE slips to one-month low on U.S. election jitters

Published 02/11/2016, 16:59
© Reuters. City workers make phone calls outside the London Stock Exchange in Paternoster Square in the City of London
UK100
-
NXT
-
DBKGn
-
AZN
-
GSK
-
STAN
-
FRES
-
INDV
-

By Alistair Smout and Atul Prakash

LONDON (Reuters) - Britain's top share index slipped to a one-month low on Wednesday as global equities suffered from nerves over the upcoming U.S. presidential election and Standard Chartered was hit by broker downgrades.

Britain's blue-chip FTSE 100 index (FTSE), down for a third straight session, closed 1 percent weaker after slipping to its lowest level since late September. It declined along with European, Asian and U.S. stock markets as polls showed the race for the White House was tightening.

Republican Donald Trump closed the gap on Democrat Hillary Clinton over the last week, according to some polls, spooking markets and prompting some to rethink bets of a Clinton victory.

"Anxious investors the world over are pricing in an even tighter U.S. election race," said Mike van Dulken, analyst at Accendo Markets. "The probability of a Clinton win may remain high but a blindside Brexit result is also still very fresh in the memory of market participants."

The top individual faller was Standard Chartered (L:STAN), which dropped again after Tuesday's worse-than-expected results. It fell 4.3 percent on Wednesday after suffering broker downgrades from Deutsche Bank (DE:DBKGn) and Natixis, with total losses rising to nearly 10 percent in two sessions.

"Revenue stability is not enough ... The current share price implies even greater revenue growth," analysts at Deutsche Bank said in a note. "We think operating leverage for Standard Chartered remains challenging and see pressure on revenues in the coming years."

However, drugmakers outperformed the broader market, with analysts saying that a Trump win could lessen the risk of a more severe drug-pricing regime in the United States. GlaxoSmithKline (L:GSK) and AstraZeneca (L:AZN) were up around 0.3 percent.

Precious metals miner Fresnillo (L:FRES) surged 3.6 percent, the top gainer in the FTSE 100 index, after prices of safe-haven gold rallied to a one-month high on uncertainty over the outcome of the U.S. election.

British retailer Next (L:NXT) rose 3.5 percent after it held its full-year profit forecast steady. With substantial domestic exposure, Next has been one of the worst performing FTSE 100 stocks this year, and slumped following Britain's vote to leave the European Union.

Peel Hunt raised its rating on the retailer to "buy" from "hold" after its results, saying like-for-like sales were negative but "not in freefall."

© Reuters. City workers make phone calls outside the London Stock Exchange in Paternoster Square in the City of London

Mid-cap drugmaker Indivior (L:INDV) surged more than 10 percent after raising its full-year revenue forecast as it sold more medicine to treat opioid addiction in the United States.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.